Celldex Therapeutics, Inc.
CLDX· Nasdaq
Released Aug 8, 2022, after the close
10-Q filed Aug 8, 2022, 39 days after period end · 0001104659-22-087222
| Metric | Q2 2022 | Q2 2021 | Q2 2020 | Q2 2019 |
|---|---|---|---|---|
| Revenue | $163.00K | $3.48M | $236.00K | $715.00K |
| EPS Diluted | -$0.77 | -$0.34 | -$0.50 | -$0.84 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Celldex Therapeutics, Inc. · CIK 744218 · Engraved from SEC EDGAR